Founded in 2001, Legend Capital (君联资本) is a leading VC&PE investor focusing on early-stage and growth-stage opportunities in China. The firm manages USD and RMB funds totaling over US$10 billion in commitments and has invested in around 700 companies across technology, healthcare, consumer, enterprise service, and intelligent manufacturing sectors.
Deal activity increased 200% year-over-year (6 deals in the last 12 months). Average disclosed round size is $321.3M (across 113 rounds with reported amounts).
Portfolio
102
Fund Size
—
Top Stage
Series B
Last 12 Mo
6
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
162 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 ClinChoice | Seed | $150M | Sep 2026 |
 VITURE | Series D | — | Feb 2026 |
 Obita | Series A | — | Jan 2026 |
| Obita | Seed | $30M | Jan 2026 |
| SSimplexity Robotics | Unknown | $289M | Jan 2026 |
 SanegeneBio | Series B | $110M | Jan 2026 |
| Obita | Seed | — | Dec 2025 |
 Neolix | Series D | $600M | Oct 2025 |
 Neolix | Series D | $600M | Oct 2025 |
| SanegeneBio | Series B | $110M | Jan 2025 |
 Angitia Biopharmaceuticals | Series C | $120M | Dec 2024 |
 Allink Biotherapeutics | Series A | $42M | Nov 2024 |
 Leapstack | Series C | — | Jan 2024 |
 Lynk Pharmaceuticals | Series C | — | Sep 2023 |
| 智智谱 | Unknown | — | Jan 2023 |
 瀚辰光翼 | Unknown | — | Jan 2023 |
| Angitia Biopharmaceuticals | Series B | $40M | Jan 2023 |
| AAngitia Bio | Series B | $40M | Jan 2023 |
| ZZhipu AI | Series B | — | Sep 2022 |
| ClinChoice | Series E | $150M | Jul 2022 |
| MMediLink | Series B | $70M | Apr 2022 |
| MMediLink Therapeutics | Series B | $70M | Apr 2022 |
| MMediLink Therapeutics | Series B | $70M | Mar 2022 |
 TuringQ | Unknown | — | Feb 2022 |
 JenaValve Technology | Series C | $100M | Jan 2022 |
Page 1 of 7
Top Co-Investors
LAV14 shared
DCM Ventures11 shared
Temasek Holdings (Private) Limited11 shared
Gaorong Capital11 shared
Hillhouse Investment10 shared
HongShan9 shared
Med-Fine Capital9 shared
LYFE Capital9 shared
Tiger Global Management, LLC8 shared
GGV Capital8 shared
Cormorant Asset Management8 shared
Lake Bleu Capital8 shared
Sequoia Capital7 shared
Morningside7 shared
OrbiMed7 shared
HighLight Capital7 shared
BioTrack Capital7 shared
Oriza7 shared
Northern Light Venture Capital6 shared
Atlas Venture6 shared
Last updated: 7 October 2026